China NT Pharma Group Company Limited (HKG:1011)

Market Cap	505.68M +622.6%
Revenue (ttm)	20.45M -3.5%
Net Income	-77.72M
EPS	-0.19
Shares Out	674.25M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	129,980
Open	n/a
Previous Close	0.7500
Day's Range	n/a
52-Week Range	0.1930 - 1.3500
Beta	-2.32
RSI	39.30
Earnings Date	Nov 7, 2025

About HKG:1011

China NT Pharma Group Company Limited, an investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People’s Republic of China. It operates through Digital Services and Sales Agency Service segments. The company acts as agent for clients to sell medical and health-related products to external customers. It also provides marketing and promotion in relation to bone health knowledge. In addition, the company is involved in trading of prescription medicines...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1995
• Employees: 21
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1011

Financial Performance

In 2024, HKG:1011's revenue was 37.96 million, an increase of 415.34% compared to the previous year's 7.37 million. Losses were -53.36 million, -62.84% less than in 2023.

Financial numbers in CNY